Terminal AZF deletions may predict micro-TESE failure in men with sY254/sY255 deletions: a next-generation sequencing study
Asian Journal of Andrology · 13.11.2026
DOI: 10.4103/aja202653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Andrology, online erschienen am 13.11.2026. Verfasst von Huan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Sciences, Central South University, Changsha 410008, Chin…. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Patients carrying azoospermia factor c (AZFc) deletions present with different phenotypes, ranging from severe oligozoospermia to non-obstructive azoospermia (NOA). We used next-generation sequencing (NGS) to investigate whether cryptic structural variations within the Y chromosome contribute to this phenotypic heterogeneity. We retrospectively analyzed 297 infertile men with sY254 and sY255 deletions, including 224 with severe oligozoospermia and 73 with NOA between January 2023 and January 2025 at the Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China. Microdissection testicular sperm extraction (micro-TESE) was performed only in the NOA subgroup, with a successful sperm retrieval rate of 50.7% (37 of 73 men). To delineate the structural complexity of AZFc, NGS was performed on a subset of 76 patients. This approach distinguished canonical b2/b4 deletions from rarer non-canonical rearrangements, including terminal deletions and duplication-containing variants. Compared with the severe oligozoospermia group, the NOA group exhibited significantly smaller testicular volumes and lower estradiol (E2) and inhibin B (INHB) levels. In addition, they exhibited higher follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels. Across the NGS subgroup, b2/b4 deletions were the predominant pattern in all phenotypic groups. Terminal AZF deletions were observed only in sperm-negative NOA patients and were absent in severe oligozoospermia and sperm-positive NOA groups. Routine endocrine markers reflected overall testicular dysfunction but did not discriminate micro-TESE outcomes within the NOA subgroup. In this cohort, terminal AZF deletions were confined to sperm-negative cases. This raises the preliminary, hypothesis-generating possibility that detailed NGS-based structural characterization may provide additional prognostic information beyond standard sequence-tagged site–polymerase chain reaction (STS-PCR). However, given the small sample size and the single-center retrospective design, these findings must be interpreted with caution.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Sciences, Central South University, Changsha 410008, China.
- Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410013, China.
- School of Medicine, Hunan Normal University, Changsha 410081, China.
Zitieren
APA
Zhang, H., Li, W. N., Zeng, S. C., & Hu, L. (2026). Terminal AZF deletions may predict micro-TESE failure in men with sY254/sY255 deletions: a next-generation sequencing study. Asian Journal of Andrology. https://doi.org/10.4103/aja202653
Vancouver
Zhang H, Li WN, Zeng SC, Hu L. Terminal AZF deletions may predict micro-TESE failure in men with sY254/sY255 deletions: a next-generation sequencing study. Asian Journal of Andrology. 2026. doi:10.4103/aja202653
BibTeX
@article{Zhang2026,
author = {Zhang, Huan and Li, Wei-Na and Zeng, Si-Cong and Hu, Liang},
title = {Terminal AZF deletions may predict micro-TESE failure in men with sY254/sY255 deletions: a next-generation sequencing study},
journal = {Asian Journal of Andrology},
year = {2026},
doi = {10.4103/aja202653}
}
EUVIMED